人炎症牙髓来源间充质干细胞体外免疫调节能力受损
本研究比较健康与炎症(不可逆性牙髓炎)人牙髓来源DPSC的体外免疫调节能力。10例健康及炎症牙髓DPSC均符合MSC基本标准,增殖、三向分化及集落形成无显著差异,但炎症来源DPSC对T淋巴细胞增殖的抑制能力显著降低,提示其免疫抑制功能受损。
要点
- 炎症牙髓DPSC仍符合MSC基本表型与分化标准
- 炎症牙髓DPSC体外免疫抑制能力显著低于健康牙髓DPSC
- 炎症状态可改变DPSC免疫调节功能,需进一步体内验证
核心结论
- 炎症牙髓来源DPSC具有典型MSC特征,但体外免疫抑制能力较健康牙髓DPSC降低。
研究设计与样本
- 体外研究,纳入10例健康牙髓和10例炎症牙髓(不可逆性牙髓炎)来源DPSC。
主要发现
- 健康与炎症牙髓DPSC在免疫表型、三向分化、集落形成单位及增殖方面无显著差异。
- 健康与炎症牙髓DPSC的免疫调节能力存在显著差异。
临床怎么用
- 使用炎症牙髓来源DPSC进行免疫调节相关应用时,需考虑其免疫抑制功能可能减弱。
局限性
- 免疫调节能力仅于体外评估,其 diminished 免疫抑制机制需进一步体内研究阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Dental pulp stem cells (DPSC) are very attractive in regenerative medicine. In this study, we focused on the characterization of the functional properties of mesenchymal stem cells derived from DPSCs. Currently, it is unknown whether inflammatory conditions present in an inflamed dental pulp tissue could alter the immunomodulatory properties of DPSCs. This study aimed to evaluate the immunomodulatory capacity in vitro of DPSCs derived from healthy and inflamed dental pulp. METHODS: DPSCs from 10 healthy and inflamed dental pulps (irreversible pulpitis) were characterized according to the minimal criteria of the International Society for Cell Therapy, proliferation, differential potential, and colony-forming units. Furthermore, the immunomodulatory capacity of DPSCs was tested on the proliferation of T lymphocytes by flow cytometry and the in vitro enzyme activity of indoleamine 2, 3-dioxygenase. RESULTS: There were no significant differences in the DPSC characteristics and properties such as immunophenotype, tridifferentiation, colony-forming units, and proliferation of the DPSCs derived from normal and inflamed pulp tissue. Furthermore, there were significant differences in the immunomodulatory capacity of DPSCs obtained from human healthy dental pulp and with the diagnosis of irreversible pulpitis. CONCLUSIONS: Our results showed that DPSCs isolated from inflamed dental pulp showed typical characteristics of MSCs and diminished immunosuppressive capacity in vitro in comparison with MSCs derived from healthy dental pulp. Further investigation in vivo is needed to clarify the mechanism of this diminished immunosuppressive capacity.
引用
- Inostroza C, Vega-Letter AM, Brizuela C, et al. Mesenchymal Stem Cells Derived from Human Inflamed Dental Pulp Exhibit Impaired Immunomodulatory Capacity In Vitro. J Endod. 2020. PMID: 32422164. doi:10.1016/j.joen.2020.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。